Fluoxetine and chronic fatigue syndrome [15]

Lancet

Volumn 347, Issue 9017, 1996, Pages 1770-1772

  Cleare, A J ^a   Wessely, S C ^a   Sharma, A ^a   Kendall, M J ^a   Oyebode, F ^a   Jones, D ^a   Lynch, S ^a   Seth, R ^a   Vercoulen, J H M M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; ANTIDEPRESSANT AGENT;

CHRONIC FATIGUE SYNDROME; HUMAN; LETTER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; SOMATIZATION; SOMATOFORM DISORDER; PATHOPHYSIOLOGY;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FATIGUE SYNDROME, CHRONIC; FLUOXETINE; HUMANS; SOMATOFORM DISORDERS;

EID: 0029995543     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90851-X     Document Type: Letter

References (20)

1. Jhmm Vercoulen Cma Swanink Fg Zitman Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome Lancet 347 1996 858 861
2. S. Wessely Chronic fatigue syndrome—the current position: 1, background, epidemiology and aetiology Primary Care Psychiatry 1 1995 21 30
3. A. Wearden R. Morriss R. Mullis L. Appleby I. Campbell A double blind, placebo-controlled trial of fluoxetine and a graded exercise programme for chronic fatigue syndrome Presented at Anglo-Portuguese C-L Psychiatry Conference March, 1996
4. Aj Cleare J. Beam T. Allain Am McGregor Rm Murray S. Wessely Contrasting neuroendocrine responses in depression and chronic fatigue syndrome J Affect Disord 35 1995 283 289
5. Amo Bakheit Po Behan Tg Dinan Ce Gray V. O'Keane Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome BMJ 304 1992 1010 1012
6. Jhmm Vercoulen Cma Swanink Fg Zitman Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome Lancet 347 1996 858 861
7. Rht Edwards Je Clague H. Gibson Tr Helliwell Muscle metabolism, histopathology, and physiology in chronic fatigue syndrome Se Staus Chronic fatigue syndrome 1994 Marcel Dekker Inc New York 241 261
8. F. Chaouloff Physical exercise and brain monoamines: a review Acta Physiol Scand 137 1989 1 13
9. Amo Bakheit Po Behan Tg Dinan Ce Gray V. O'Keane Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome BMJ 304 1992 1010 1012
10. Pm Jakeman Je Hawthorne Srj Maxwell Mj Kendall G. Holder Evidence for downregulation of hypothalamic 5-hydroxytryptamine receptor function endurance-trained athletes Exp Physiol 79 1994 461 464
11. Jhmm Vercoulen Cma Swanink Fg Zitman Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome Lancet 347 1996 858 861
12. Ar Lloyd K. Hickie A. Brockman Immunologic and psychologic therapy for patients with chronic fatigue syndrome, a double-blind, placebo-controlled trial Am J Med 94 1993 197 203
13. Se Straus Jk Dale M. Tobi Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial N Engl J Med 319 1988 1692 1698
14. Im Cox Mj Campbell D. Dowson Red blood cell magnesium and chronic fatigue syndrome Lancet 337 1991 757 760
15. D. Bonner M. Ron T. Chalder S. Butler S. Wessely Chronic fatigue syndrome: a follow up study J Neurol Neurosurg Psychiatry 57 1994 617 621
16. Jhmm Vercoulen Cma Swanink Jmd Galama Jfm Fennis Jwm van der Meer G. Bleijenberg Prognosis in chronic fatigue syndrome (CFS): a prospective study on the natural course J Neurol Neurosurg Psychiatry 60 1996 489 494
17. Mc Sharpe Lc Archard Je Banatvala Chronic fatigue syndrome: guidelines for research J R Soc Med 84 1991 118 121
18. K. Fukuda E. Straus I. Hickie The chronic fatigue syndrome: a comprehensive approach to its definition and study Ann Intern Med 121 1994 953 959
19. Amo Bakheit Po Behan Tg Dinan Ce Gray V. O'Keane Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome BMJ 304 1992 1010 1012
20. Aj Cleare J. Beam T. Allain Am McGregor Rm Murray S. Wessely Contrasting neuroendocrine responses in depression and chronic fatigue syndrome J Affect Disord 35 1995 283 289